CA2928350C - Compositions for oral administration of zoledronic acid or related compounds for treating disease - Google Patents
Compositions for oral administration of zoledronic acid or related compounds for treating disease Download PDFInfo
- Publication number
- CA2928350C CA2928350C CA2928350A CA2928350A CA2928350C CA 2928350 C CA2928350 C CA 2928350C CA 2928350 A CA2928350 A CA 2928350A CA 2928350 A CA2928350 A CA 2928350A CA 2928350 C CA2928350 C CA 2928350C
- Authority
- CA
- Canada
- Prior art keywords
- zoledronic acid
- dosage form
- oral dosage
- mammal
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/063,979 | 2013-10-25 | ||
| US14/063,979 US8802658B2 (en) | 2012-05-14 | 2013-10-25 | Compositions for oral administration of zoledronic acid or related compounds for treating disease |
| US14/279,241 | 2014-05-15 | ||
| US14/279,241 US20140249317A1 (en) | 2012-05-14 | 2014-05-15 | Compositions for oral administration of zoledronic acid or related compounds for treating disease |
| PCT/US2014/050427 WO2015060924A1 (en) | 2013-10-25 | 2014-08-08 | Compositions for oral administration of zoledronic acid or related compounds for treating disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2928350A1 CA2928350A1 (en) | 2015-04-30 |
| CA2928350C true CA2928350C (en) | 2018-01-09 |
Family
ID=52993341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2928350A Active CA2928350C (en) | 2013-10-25 | 2014-08-08 | Compositions for oral administration of zoledronic acid or related compounds for treating disease |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3060220A4 (zh) |
| JP (6) | JP6166471B2 (zh) |
| KR (3) | KR101975687B1 (zh) |
| CN (2) | CN108434154A (zh) |
| AU (2) | AU2014340649C1 (zh) |
| CA (1) | CA2928350C (zh) |
| HK (1) | HK1257400A1 (zh) |
| IL (2) | IL245287A0 (zh) |
| MX (1) | MX2016005396A (zh) |
| MY (1) | MY176246A (zh) |
| SG (3) | SG10201609548UA (zh) |
| WO (1) | WO2015060924A1 (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9999629B2 (en) | 2012-05-14 | 2018-06-19 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US10413560B2 (en) | 2012-05-14 | 2019-09-17 | Antecip Bioventures Ii Llc | Dosage forms for oral administration of zoledronic acid or related compounds for treating disease |
| US9956238B2 (en) | 2014-05-15 | 2018-05-01 | Antecip Bioventures Ii Llc | Compositions for administration of zoledronic acid or related compounds for treating low back pain |
| US10016445B2 (en) | 2012-05-14 | 2018-07-10 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US10493085B2 (en) | 2012-05-14 | 2019-12-03 | Antecip Bioventures Ii Llc | Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases |
| US11654152B2 (en) | 2012-05-14 | 2023-05-23 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating disease |
| US10413561B2 (en) | 2012-05-14 | 2019-09-17 | Antecip Bioventures Ii Llc | Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases |
| US10463682B2 (en) | 2012-05-14 | 2019-11-05 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating low back pain |
| US10350227B2 (en) | 2012-05-14 | 2019-07-16 | Antecip Bioventures Ii Llc | Neridronic acid for treating complex regional pain syndrome |
| CN108434154A (zh) * | 2013-10-25 | 2018-08-24 | 安泰赛普生物风投二代有限责任公司 | 用于治疗疾病的唑来膦酸或相关化合物的经口施用组合物 |
| CN109891021B (zh) | 2016-10-28 | 2022-04-12 | 三菱化学株式会社 | 碳纤维用上浆剂、碳纤维用上浆剂的水分散液、和附着有上浆剂的碳纤维束 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2321864A1 (en) * | 1998-12-25 | 2000-07-06 | Toray Industries, Inc. | Interleukin-6 production inhibitor |
| GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
| MXPA03010007A (es) * | 2001-05-02 | 2004-02-12 | Novartis Ag | USO DE BISFOSFONATOS EN EL TRATAMIENTO DE METASTASIS DE HUESO ASOCIADO CON CANCER DE PRoSTATA. |
| US7875597B2 (en) * | 2002-07-24 | 2011-01-25 | New York University | Treatment of spinal mechanical pain |
| AU2003280373A1 (en) * | 2002-10-15 | 2004-05-04 | Novartis Ag | Method of administering bisphosphonates |
| EP1567533B1 (en) * | 2003-07-03 | 2009-03-11 | Teva Pharmaceutical Industries Ltd. | Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
| AR046773A1 (es) * | 2003-12-23 | 2005-12-21 | Novartis Ag | Formulaciones farmaceuticas de bisfosfonatos |
| HUE034784T2 (en) * | 2009-07-31 | 2018-02-28 | Gruenenthal Gmbh | Crystallization process and bioavailability |
| LT2531200T (lt) * | 2010-02-06 | 2017-09-25 | Grünenthal GmbH | Kristalizacijos būdas ir bioprieinamumas |
| WO2012071517A2 (en) * | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
| AU2013262995B2 (en) * | 2012-05-14 | 2016-09-01 | Antecip Bioventures Ii Llc | Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions |
| CN108434154A (zh) * | 2013-10-25 | 2018-08-24 | 安泰赛普生物风投二代有限责任公司 | 用于治疗疾病的唑来膦酸或相关化合物的经口施用组合物 |
-
2014
- 2014-08-08 CN CN201810150156.6A patent/CN108434154A/zh active Pending
- 2014-08-08 KR KR1020177013050A patent/KR101975687B1/ko active IP Right Grant
- 2014-08-08 EP EP14856165.7A patent/EP3060220A4/en not_active Withdrawn
- 2014-08-08 CN CN201480069491.3A patent/CN105960240B/zh active Active
- 2014-08-08 KR KR1020167012645A patent/KR101739244B1/ko active IP Right Grant
- 2014-08-08 AU AU2014340649A patent/AU2014340649C1/en active Active
- 2014-08-08 WO PCT/US2014/050427 patent/WO2015060924A1/en active Application Filing
- 2014-08-08 SG SG10201609548UA patent/SG10201609548UA/en unknown
- 2014-08-08 CA CA2928350A patent/CA2928350C/en active Active
- 2014-08-08 JP JP2016526009A patent/JP6166471B2/ja active Active
- 2014-08-08 SG SG10201800001VA patent/SG10201800001VA/en unknown
- 2014-08-08 SG SG11201603042TA patent/SG11201603042TA/en unknown
- 2014-08-08 MY MYPI2016701480A patent/MY176246A/en unknown
- 2014-08-08 KR KR1020197001788A patent/KR20190009428A/ko not_active Application Discontinuation
- 2014-08-08 MX MX2016005396A patent/MX2016005396A/es unknown
-
2016
- 2016-04-21 IL IL245287A patent/IL245287A0/en unknown
-
2017
- 2017-02-07 AU AU2017200832A patent/AU2017200832A1/en not_active Abandoned
- 2017-06-22 JP JP2017121884A patent/JP6453387B2/ja active Active
- 2017-08-23 IL IL254123A patent/IL254123A0/en unknown
-
2018
- 2018-12-12 JP JP2018232467A patent/JP6802245B2/ja active Active
- 2018-12-26 HK HK18116608.0A patent/HK1257400A1/zh unknown
-
2020
- 2020-11-26 JP JP2020196080A patent/JP7136487B2/ja active Active
-
2022
- 2022-08-25 JP JP2022134019A patent/JP2022162105A/ja active Pending
-
2024
- 2024-02-07 JP JP2024017350A patent/JP2024040304A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9616077B2 (en) | Dosage forms for oral administration of zoledronic acid or related compounds for treating disease | |
| US9616078B2 (en) | Dosage forms for oral administration of zoledronic acid or related compounds for treating disease | |
| AU2013262995B2 (en) | Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions | |
| CA2928350C (en) | Compositions for oral administration of zoledronic acid or related compounds for treating disease | |
| AU2014340649A1 (en) | Compositions for oral administration of zoledronic acid or related compounds for treating disease | |
| WO2016172453A1 (en) | Pharmacodynamic effects after oral administration of zoledronic acid or related compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160421 |